Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions demonstrate a fair degree of engagement, with references to key statistics like the 29% occurrence rate of delirium in diabetic patients and the potential benefits of medications like metformin and intranasal insulin, which are seen as impactful, guiding future research and clinical approaches. The tone varies from informative to cautiously optimistic, emphasizing the study's relevance to medical practice.
Most discussions recognize the findings of the systematic review, especially regarding the increased risk of delirium in diabetic patients and potential protective effects of certain medications.
Participants show moderate interest, mentioning statistics like the 29% occurrence rate and details about medication effects, indicating engagement but not deep controversy.
Comments often reference specific data points and implications of the research, suggesting active reading and consideration of its significance.
The discussions highlight the importance of the findings for clinical practice, such as implications for medication management in diabetic patients to reduce delirium risk.
【DM例におけるせん妄リスクと血糖降下薬/ CD [May 19]】 DM対象研究52報併合 [124,291例] ： ・せん妄発症率は29% [95%CI：26-33]。Iスクエア 99.6%。 ・メトホルミンでRRは0.71 [95%CI：0.59-0.85] [8報解析]。 https://t.co/NwkUaMF1Zr
This video discusses the link between diabetes mellitus and the onset of delirium. It highlights findings from recent studies showing increased delirium risk in diabetic patients and explores potential protective roles…
This systematic review and meta-analysis evaluated 52 studies on the link between diabetes mellitus and delirium. The findings indicate that diabetes significantly increases the risk of developing delirium, with…
【DM例におけるせん妄リスクと血糖降下薬/ CD [May 19]】 DM対象研究52報併合 [124,291例] ： ・せん妄発症率は29% [95%CI：26-33]。Iスクエア 99.6%。 ・メトホルミンでRRは0.71 [95%CI：0.59-0.85] [8報解析]。 https://t.co/NwkUaMF1Zr